Sitko Kevin R, Peragallo Jason H, Bidot Samuel, Biousse Valerie, Newman Nancy J, Bruce Beau B
Department of Ophthalmology, Emory University, Atlanta, Georgia.
Department of Ophthalmology, Emory University, Atlanta, Georgia; Department of Pediatrics, Emory University, Atlanta, Georgia.
Ophthalmology. 2016 Jan;123(1):198-202. doi: 10.1016/j.ophtha.2015.09.024. Epub 2015 Oct 16.
The Titmus Stereotest (Stereo Optical Co., Inc., Chicago, IL) has been used to estimate visual acuity (VA) in the evaluation of nonorganic visual loss. Previous predictions were derived from optical degradation of VA in normal subjects and may not account for the variability seen in patients with neuro-ophthalmic pathologies included in the differential diagnosis of nonorganic visual loss. The purpose of this study was to evaluate the relationship between Titmus stereoacuity and minimal VA based on a real-world testing environment.
Cross-sectional observational study.
All patients treated at the authors' neuro-ophthalmology service between April 25, 2014, and July 31, 2014.
All subjects underwent routine neuro-ophthalmic examination, including Titmus stereoacuity measurements. A compound Bayesian logit-lognormal model accounting for heteroscedasticity was used to determine 95% and 99% prediction intervals of the worse eye's near VA based on stereoacuity. Logarithm of the minimum angle of resolution VA and log stereoacuity were analyzed.
Titmus stereoacuity and worse eye VA.
Of 561 patients, 364 subjects 11 to 91 years of age were included. Titmus stereoacuity was associated positively with VA: 9 circles correct (40 seconds of arc) indicated VA of at least 20/40 with 95% confidence and VA of at least 20/79 with 99% confidence; 6 circles correct (80 seconds of arc) indicated VA of at least 20/62 and 20/180, respectively; and 4 circles correct (140 seconds of arc) indicated VA of at least 20/110 and 20/570, respectively.
When fully accounting for individual variation and the full spectrum of neuro-ophthalmic diseases affecting VA, stereoacuity remains associated with VA, but previous commonly used VA estimates based on stereoacuity overestimated VA. Our results more accurately predict minimum VA from Titmus stereoacuity and should be used preferentially when evaluating patients with suspected nonorganic visual loss. We demonstrated that Titmus stereoacuity cannot definitively establish normal VA, and therefore can suggest, but not fully establish, the diagnosis of nonorganic visual loss.
Titmus立体视测试(Stereo Optical Co., Inc., 芝加哥,伊利诺伊州)已被用于评估非器质性视力丧失时的视敏度(VA)。先前的预测是基于正常受试者视敏度的光学退化得出的,可能无法解释在非器质性视力丧失鉴别诊断中所包含的神经眼科疾病患者中观察到的变异性。本研究的目的是在真实测试环境中评估Titmus立体视锐度与最小视敏度之间的关系。
横断面观察性研究。
2014年4月25日至2014年7月31日期间在作者的神经眼科门诊接受治疗的所有患者。
所有受试者均接受常规神经眼科检查,包括Titmus立体视锐度测量。使用考虑异方差性的复合贝叶斯逻辑对数正态模型,根据立体视锐度确定较差眼近视力的95%和99%预测区间。分析最小分辨角视敏度的对数和对数立体视锐度。
Titmus立体视锐度和较差眼视敏度。
在561例患者中,纳入了364例年龄在11至91岁之间的受试者。Titmus立体视锐度与视敏度呈正相关:9个圆圈正确(40角秒)表明视敏度至少为20/40,95%置信度下视敏度至少为20/79,99%置信度下视敏度至少为20/79;6个圆圈正确(80角秒)分别表明视敏度至少为20/62和20/180;4个圆圈正确(140角秒)分别表明视敏度至少为20/110和20/570。
在充分考虑个体差异和影响视敏度的各种神经眼科疾病后,立体视锐度仍与视敏度相关,但先前基于立体视锐度常用的视敏度估计高估了视敏度。我们的结果能更准确地从Titmus立体视锐度预测最小视敏度,在评估疑似非器质性视力丧失的患者时应优先使用。我们证明Titmus立体视锐度不能明确确定正常视敏度,因此可以提示但不能完全确立非器质性视力丧失的诊断。